Welcome at ImmbiCon

ImmbiCon was founded in October, 2011 by Dr. Roland Kurrle
to support customers creating maximum commercial value of innovative, scientific projects or technologies (“connecting science and business“).

The consulting business of ImmbiCon is focussed on research and development projects in the field of immunology, immunotherapeutics and biotherapeutics.

The founder’s scientific advice is based on his distinct record of success and
on his more than 30 years of experience as executive professional in the pharmaceutical industry.

Based on thorough data analyses and working closely together with customers, ImmbiCon will increase the likelihood of commercial success of projects by generating optimized discovery- or development strategies or, if applicable,  will support In- or Out-Licensing  processes.